Back to Australia
Australia
21 September 2026
Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion
Sept 21 (Reuters) - Australia's Telix Pharmaceuticals said on Monday it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1. 65 billion on a cash- and debt-free basis.
About this report
This article contains independently written commentary and community perspective from Downunder Voices.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.
